Researchers have been investigating a drug commonly used to treat parasitic diseases to see if it can be used for cancer treatment. They found that fenbendazole, also known as MBZ or benzimidazole, may be effective in killing cancer cells by binding to the microtubules within them. Microtubules are like little ropes that help a cell to grow and move, but fenbendazole prevents these microtubules from working correctly, which causes the cancer cells to die.
The drug has been shown to be effective in animal tests, but it is not yet approved for use by the FDA. Some patients have anecdotal stories of using fenbendazole for cancer, but the results of scientific studies are limited and inconsistent. Despite this, a growing number of people are trying the drug.
Taking lessons learned in battling viruses like hepatitis and the common cold, Stanford virologist Jeffrey Glenn, MD, PhD, and his team have been working on new ways to fight cancer. Their efforts have led to a promising collaboration and a novel type of cancer drug that appears effective in mice.
This new type of cancer drug works by blocking the protein kinase RAS, which is involved in signaling the growth of certain cancer cells. It also inhibits the cellular mechanism that allows cancer cells to grow, and it blocks cancer cells from getting their primary energy source – glucose.
Although fenbendazole can kill cancer cells on its own, it is more effective when combined with vitamins. In animal studies, combining the drug with vitamin E, B6, and D resulted in significant reductions in tumor growth. The drug is also effective when used in combination with traditional chemotherapy drugs.
While it is not proven to be safe for humans, the evidence is strong enough to recommend a trial of the drug in some people with certain types of cancer. The positive results of these trials could mean that fenbendazole will become an important part of the arsenal of cancer-fighting medicines.
It is important to note that a person should not try this medication without consulting with their physician. The information presented in this article is based on research and anecdotal reports. A physician should assess a patient’s unique medical history and current health status before prescribing any medication. fenbendazole cancer treatment